4//SEC Filing
Nichols Andrew John 4
Accession 0001179110-20-001600
CIK 0001454789other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 1:01 PM ET
Size
14.5 KB
Accession
0001179110-20-001600
Insider Transaction Report
Form 4
Nichols Andrew John
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2020-02-12+60,000→ 60,000 totalExercise: $5.32Exp: 2030-02-11→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]This option was granted on February 12, 2020 and is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of February 12, 2020 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.
Documents
Issuer
CATABASIS PHARMACEUTICALS INC
CIK 0001454789
Entity typeother
Related Parties
1- filerCIK 0001683749
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 1:01 PM ET
- Size
- 14.5 KB